CB-011
CB11A
Phase 1 mab active
Quick answer
CB-011 for Relapsed/Refractory Multiple Myeloma is a Phase 1 program (mab) at Caribou Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Caribou Biosciences
- Indication
- Relapsed/Refractory Multiple Myeloma
- Phase
- Phase 1
- Modality
- mab
- Status
- active